Fisher & Paykel Healthcare (FSPKF) Receiving Somewhat Favorable News Coverage, Report Shows

Press coverage about Fisher & Paykel Healthcare (OTCMKTS:FSPKF) has trended somewhat positive this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fisher & Paykel Healthcare earned a media sentiment score of 2.00 on their scale. InfoTrie also assigned headlines about the company an news buzz score of 2 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock’s share price in the next several days.

Shares of OTCMKTS:FSPKF opened at $10.53 on Friday. Fisher & Paykel Healthcare has a 12-month low of $8.30 and a 12-month high of $10.80.

Separately, Goldman Sachs Group upgraded Fisher & Paykel Healthcare from a “sell” rating to a “neutral” rating in a research note on Thursday, February 21st.

COPYRIGHT VIOLATION WARNING: “Fisher & Paykel Healthcare (FSPKF) Receiving Somewhat Favorable News Coverage, Report Shows” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA).

Further Reading: What is a Buy-Side Analyst?

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with's FREE daily email newsletter.